It is great to see you here. To see all contents of the website, please register or restore your access.
We believe you will come back gladly.
Our mission is to make molecular in-vitro diagnostics simple and routine – so that patients can be diagnosed accurately, quickly and efficiently. That's why it's essential for us to make the entire manufacturing process as smooth as possible. Right now, we are establishing a new company division that will specialize in the development and production of oligonucleotides that are essential for the manufacture of PCR reagents.
A university degree in the field is a prerequisite. You should be well experienced biochemist in automated solid-phase synthesis techniques specializing in DNA/RNA synthesis.
Place of employment: Brno, Vienna Point complex
Start date: immediately
If you are interested in the position of please send your CV and cover letter in English to e-mail: [obfuscate_1_|105|102|94|60|100|100|101|97|108|111|110|102|98|42|96|110|100]
In the subject line, please indicate the position.
Thank you for your interest in GeneProof a.s.
If you do not hear from us within 4 weeks, we will prioritize another candidate in the selection process.
Thank you for your understanding.
By submitting your CV, you consent to the processing and storage of your personal data in accordance with Act No. 101/2000 Coll. on the Protection of Personal Data. The selection procedure may be cancelled at any time during the selection process. By submitting your personal data on the basis of this advertisement, you consent to the processing and storage of your personal data in the database for the purposes of this and, where applicable, other vacancy selection procedures, until your consent is withdrawn. At the same time, you confirm that the information provided in the CV is true and accurate.
+420 543 211 679
+420 730 176 222
GeneProof offers a unique PCR testing solution that provides differential diagnostics of many pathogens
Our products’ quality, safety, and performance are fully compliant with the new rules for in vitro…